T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
Clinical trial NCT03531736 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03531736
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2027-05-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.